Wednesday, February 8, 2012

Velmedix gets $10.2M in Series B funds, adds CEO and VP

Velomedix said it has closed $10.2 million in Series B funding.
In addition, the Menlo Park-based development stage medical device company named Jeff Gold as CEO and Michael Moore and vice president of operations.

No comments:

Post a Comment